ECT revisited: Impact on major depression in borderline personality disorder

Australian and New Zealand Journal of Psychiatry

Volumn 45, Issue 11, 2011, Pages 1003-1004

  Gescher, Dorothee Maria ^a   Cohen, Simon ^a   Ruttmann, Axel ^a   Malevani, Jaroslav ^a  

^a Department of Orthopedic Surgery   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; MOOD STABILIZER; NEUROLEPTIC AGENT; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR;

ADULT; BORDERLINE STATE; CASE REPORT; DISEASE SEVERITY; ELECTROCONVULSIVE THERAPY; FEMALE; HOSPITAL CARE; HUMAN; LENGTH OF STAY; LETTER; MAJOR DEPRESSION; POSTTRAUMATIC STRESS DISORDER; SUICIDAL IDEATION; TREATMENT RESPONSE;

ADULT; BORDERLINE PERSONALITY DISORDER; DEPRESSIVE DISORDER, MAJOR; ELECTROCONVULSIVE THERAPY; FEMALE; HUMANS; SUICIDAL IDEATION;

EID: 80555145972     PISSN: 00048674     EISSN: 14401614     Source Type: Journal    
DOI: 10.3109/00048674.2011.617723     Document Type: Letter

References (10)

1. FDA Medical Devices Advisory Committee. Meeting to discuss the classifi cation of electroconvulsive therapy devices (ECT). FDA Executive summary. 2011. Silver Spring, MD: US Food and Drug Administration, 2011. [Cited 16 June 2011.] Available from URL: Http://www.fda.gov/downloads/AdvisoryCommit-tees/ CommitteesMeetingMaterials/MedicalDevices/MedicalDevicesAdvisory-Committee/ NeurologicalDevices%20Panel/UCM240933.pdf
2. American Psychiatric Association, Weiner RD. The practice of electroconvulsive therapy: Recommendations for treatment, training, and privileging. A Task Force report of the American Psychiatric Association, second edition. Washington, DC: American Psychiatric Press, 2001.
3. UK ECT Review Group. Effi cacy and safety of electroconvulsive therapy in depressive disorders: A systematic review and metaanalysis. The UK ECT Review Group. Lancet 2003; 361:799-808.
4. American Psychiatric Association. Practice guideline for the treatment of patients with major depressive disorder, second edition. American Psychiatric Association Practice Guidelines, 2008.
5. Arlington, VA: APA. [Cited 14 June 2010.] Available from URL: Http://www.psychiatryonline.com/pracGuide/loadGuidelinePdf. aspx?fi le - MDD2e-05-15-06.
6. Newton-Howes G, Tyrer P, Johnson T. Personality disorder and the outcome of depression: Meta-analysis of published studies. Br J Psychiatry 2006; 188:13-20.
7. Gescher DM and Malevani J. [Electroconvulsive therapy for major depression in borderline personality disorder. Article in German] Fortschr Neurol Psychiatr 2011; Jun 15. [Epub ahead of print].
8. Ryle A. Cognitive analytic therapy of borderline personality disorder: The model and the method. New York: Wiley, 1997.
9. Chanen AM, Jackson HJ, McCutcheon LK et al. Early intervention for adolescents with borderline personality disorder: Quasiexperimental comparison with treatment as usual. Aust N Z J Psychiatry 2009; 43:397-408.
10. Lieb K, Völlm B, Rücker G, Timmer A, Stoffers JM. Pharmacotherapy for borderline personality disorder: Cochrane systematic review of randomised trials. Br J Psychiatry 2010; 196:4-12.